Navigation Links
Shire to Acquire FerroKin BioSciences, Inc., and its Phase 2 Iron Chelator Treatment
Date:3/15/2012

DUBLIN, March 15, 2012 /PRNewswire/ --

Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that it has signed an agreement to acquire FerroKin BioSciences, Inc., for an upfront payment of $100 million, payable in cash at closing, plus potential post-closing milestone payments of up to $225 million, depending upon the achievement of certain clinical development, regulatory and net sales targets.

  • A strategic step in building Shire's hematology business (which already includes Xagrid and a growing development pipeline)
  • Adds a differentiated product in development (iron chelator FBS0701), with global rights, in a global market currently worth over $900 million and growing(1)
  • Serves chronic patient need for treatment of iron overload following numerous blood transfusions.  Excess iron in vital organs such as the liver and heart increases the risk of organ failure and is the principal cause of death in transfusion-dependent patients(2)
  • Consistent with Shire strategy of developing and commercializing differentiated specialist products prescribed by specialist physicians (hematologists/ hematologist-oncologists) served by a small sales force
  • FBS0701 will be developed to demonstrate clinical efficacy and an attractive safety profile relative to currently approved chelating agents:
  • Global filing planned for indications for Myelodysplastic Syndrome and hemoglobinopathies initially
  • Phase 2 studies underway with additional trials planned

    SOURCE Shire plc
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related biology technology :

    1. Shire plc: Continued Strong Product Sales Performance in Q3: On Track to Deliver Significant 2011 Earnings Growth
    2. NHS Northamptonshire Chief Executive John Parkes Accepts Visiting Professorship
    3. FDA Approves Shires FIRAZYR® (icatibant injection) for Acute Attacks of Hereditary Angioedema (HAE)
    4. Shires Quarterly Revenues Grow by 25% to $1 Billion for the First Time
    5. Shire Files Lawsuits Against Watson and Roxane for Infringement of VYVANSE(R) (lisdexamfetamine dimesylate) Patents
    6. Shire Presents Data at ACMG for Fabry and Gaucher Patients Who Switched to Replagal® (agalsidase alfa) and VPRIV® (velaglucerase alfa for injection)
    7. Shire Reports Positive Signal Finding Study of Investigative Use of Vyvanse(R) (lisdexamfetamine dimesylate) Capsules as Adjunctive Treatment in Major Depressive Disorder
    8. Shire plc: Continued Excellent Performance in Q3, Full Year Earnings Expectations Increased, New Value in Pipeline Emerging
    9. Shire Announces Results of the Tender Offer for Movetis NV and Commencement of Squeeze-Out Tender Period
    10. Reportlinker Adds Shire plc: PharmaVitae Profile
    11. Shire Announces European Approval of VPRIV(R) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/6/2015)... leading Regulatory Service provider, today announced that it has opened a new ... . Navitas, expansion into Latin America will ... , the third largest economy in Latin America . ... ... regulatory professionals in close to or the same time zone and ...
    (Date:7/3/2015)... ... July 03, 2015 , ... The Alexander Group, a ... service industries alike-- typically known for its consummate professionalism-- embarks each year in ... and break from their day jobs. , "Our motto has always been work ...
    (Date:7/3/2015)... , July 3, 2015 ... 22. september 2015 på  http://www.openinnovationinscience.at om ... der finder sted i Wien ... undersøgelse af internationale forskere og videnskabsmænd foretaget ... to største udfordringer for sundhedsvidenskaben manglen på ...
    (Date:7/2/2015)... PALO ALTO, Calif. (PRWEB) , ... July 02, 2015 , ... ... designed to improve an individual’s quality of sleep, launched its Indiegogo campaign on June ... and functionality: Luzi's voice command technology makes it effortless to use, while the integration ...
    Breaking Biology Technology:Navitas Launches Latin American Regulatory Operations Hub in Bogota, Colombia 2Navitas Launches Latin American Regulatory Operations Hub in Bogota, Colombia 3The Alexander Group Declares Their Independence with a Bit of Levity 2Lancering af verdens første åbne innovationsprogram til uddannelse af forskere 2Lancering af verdens første åbne innovationsprogram til uddannelse af forskere 3Luzi Smart Lamp Recently Launched Indiegogo Campaign 2Luzi Smart Lamp Recently Launched Indiegogo Campaign 3
    ... ... and Medical Affairs , ... Charlottesville, VA, San Diego, CA, New York, NY and Paris, France (PRWeb) -- ... marketing, compliance, R&D and medical affairs announces that it has secured an equity investment ...
    ... , SEATTLE, Sept. 10 Cell Therapeutics, Inc. ... the Biotech Industry conference on Wednesday, September 16, 2009, at 10:30 AM ... 16, 2009, at the Millennium Broadway Hotel in New York. The ... the presentation. The webcast can be accessed at www.celltherapeutics.com ...
    ... University lab of James Tour have brought graphite,s potential ... to reality and created the potential for reprogrammable gate ... circuit logic design. In a paper published ... and postdoctoral associate Alexander Sinitskii show how they,ve used ...
    Cached Biology Technology:OpenQ Secures Investment from Leading Mid-Atlantic Venture Firm 2OpenQ Secures Investment from Leading Mid-Atlantic Venture Firm 3Graphitic memory techniques advance at Rice 2Graphitic memory techniques advance at Rice 3
    (Date:6/17/2015)... , June 17, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced that Xiaomi, one of the ... ® ClearPad ® family of capacitive ... integrated circuits (DDICs) for its latest smartphones, the ... ClearPad for full in-cell display solutions and DDICs ...
    (Date:6/16/2015)... 16, 2015 Fingerprint Cards (FPC) raises ... it will amount to at least 340 MSEK to that ... rapid increase in market growth and orders received the revenue ... that revenue for 2015 will exceed 1,500 MSEK to an ... 2,200 MSEK. Due to receipt of orders of ...
    (Date:6/11/2015)... 2015 Daon, a global leader in ... IdentityX Mobile Authentication Platform v4.0 has been FIDO ... an industry consortium launched in 2013 to revolutionize ... authentication.  In order to receive certification, a company,s ... of tests that measure compliance and ensure interoperability ...
    Breaking Biology News(10 mins):Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 2Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 3Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 2Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 3Daon's IdentityX Mobile Authentication Platform One of First Products to be Certified by FIDO Alliance 2
    ... mitigating greenhouse-gas emissions and the assumption that corals can adapt ... safe, shows a study now published in Nature Climate ... subject to severe degradation. Coral reefs house almost a ... services including coastal protection, tourism and fishing to ...
    ... team, led by Anhui Medical University and BGI, has ... (MVK) mutations link to disseminated superficial actinic porokeratosis (DSAP). ... pathogenesisof DSAP, and sheds an eye-opening insight into its ... published online in Nature Genetics ., DSAP is ...
    ... Eye injuries in war have changed and ... and strategies have evolved. Today,s soldiers face threats ... protected by body armor. Military experts and ophthalmologists from ... will convene in Boston, Mass., on Sept. 18 to ...
    Cached Biology News:Most coral reefs are at risk unless climate change is drastically limited 2Most coral reefs are at risk unless climate change is drastically limited 3Chinese scientists discover MVK mutations associated with DSAP 2
    Human SDNSF/MCFD2 Biotinylated Affinity Purified PAb...
    8.1.1...
    ... and efficient purification of DNA and oligonucleotides ... by gravity flow.Prepacked with Sephadex G-25 DNA ... CG/ICP Biocide.Available in three sizes depending on ... ml (NAP-10) or 2.5 ml (NAP-25).Useful for ...
    Human Serpin A3 MAb (Clone 213907)...
    Biology Products: